Literature DB >> 12357197

Cutaneous rosai-dorfman disease is a distinct clinical entity.

Thomas Brenn1, Eduardo Calonje, Scott R Granter, Niamh Leonard, Wayne Grayson, Christopher D M Fletcher, Phillip H McKee.   

Abstract

Rosai-Dorfman disease (RDD) is a rare but distinctive clinicopathologic entity of unknown etiology affecting lymph nodes as well as extranodal sites. Although cutaneous involvement in RDD is common, purely cutaneous disease is rare and not well documented. We report 22 patients with cutaneous and superficial subcutaneous RDD. The lesions presented as papules and nodules, often with discoloration (9/22) and frequent multifocality (13/22), without predilection for a specific site of the body. Age distribution was wide and ranged from 15 to 68 years, with a median of 43.5 years. Of the 17 patients for whom information on racial background was available, 7 were Asian, 8 were white, and 2 were black, with a marked female predominance (2:1). The lesions resolved in 6 of 13 patients for whom follow-up data were available, regardless of the treatment given. Lesions persisted or recurred in 7 patients. Histologically, the lesions are invariably characterized by a proliferation of polygonal S100-positive histiocytes showing emperipolesis and a mixed inflammatory infiltrate. This study characterizes the histologic spectrum of cutaneous RDD in regard to variation in the numbers of typical S100-positive histiocytes and emperipolesis, variation in the quality and quantity of the inflammatory response, and the degree of stromal fibrosis, which resulted in a strikingly storiform growth pattern in six lesions and a lobulated pattern in two lesions. Whereas the clinical as well as histologic appearance of the cutaneous and subcutaneous lesions in the purely extranodal forms of RDD is indistinguishable from that of systemic RDD, this study emphasizes that purely cutaneous RDD is a distinct clinical entity in regard to its epidemiology and remains localized to the skin even with long-term follow-up. Patients with purely cutaneous RDD are of an older age at onset of disease (median = 43.5 years), with a reversed male/female ratio. There are no significant systemic extracutaneous or serologic manifestations. Whereas systemic RDD is commonly seen in blacks and only rarely reported in Orientals, the majority of the patients in this series with purely cutaneous RDD are Asians and whites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12357197     DOI: 10.1097/00000372-200210000-00001

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  34 in total

1.  Rosai-Dorfman disease involving the neurohypophysis.

Authors:  Fabio Rotondo; David G Munoz; Richard G Hegele; Bruce Gray; Nasima Khatun; Michael Bonert; Kalman Kovacs
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

2.  Relapsing uveitis in association with presumed sinus histiocytosis.

Authors:  Mizue Nakashima; Yoshie Matsui; Setsu Kobayashi
Journal:  Jpn J Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 2.447

3.  Cutaneous rosai-dorfman disease persisting after surgical excision: report of a case treated with acitretin.

Authors:  Katherine Fening; Mark Bechtel; Sara Peters; Matthew Zirwas; Kamruz Darabi
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

Review 4.  Bilateral anterior granulomatous uveitis associated with cutaneous Rosai-Dorfman disease.

Authors:  Juan G Gaviria; Daniel A Johnson; Marsha C Kinney; Liana H Proffer; Jacqueline M Losi-Sasaki; Eric W Kraus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-30       Impact factor: 3.117

5.  Cutaneous Rosai-Dorfman disease in a middle-aged man: A case report.

Authors:  Min Yang; Jianmin Chang
Journal:  Exp Ther Med       Date:  2015-06-18       Impact factor: 2.447

6.  Rosai-Dorfman disease presenting as multiple soft tissue masses.

Authors:  Phillip M Young; Mark J Kransdorf; H Thomas Temple; Fatemeh Mousavi; Philip G Robinson
Journal:  Skeletal Radiol       Date:  2005-05-14       Impact factor: 2.199

7.  Soft Tissue Rosai-Dorfman Disease: Case report.

Authors:  Rubyath C Rajib; Rajasekharan Pillai; Ibrahim A Sulaiman; Ibrahim Al-Haddabi
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

8.  Sinus histiocytosis with massive lymphadenopathy Rosai-Dorfman: three unusual manifestations.

Authors:  Gudrun Ratzinger; Bettina Zelger; Walter Höbling; Gregor Mikuz; Bernhard W Zelger
Journal:  Virchows Arch       Date:  2003-12       Impact factor: 4.064

9.  Case for diagnosis. Cutaneous Rosai-Dorfman disease.

Authors:  Han Ma; Huaiqiu Huang; Meirong Li; Wei Lai; Chun Lu
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

10.  Possible association of cutaneous Rosai-Dorfman disease and chronic Crohn disease: a case series report.

Authors:  Katrin A Salva; Melissa Stenstrom; Jonith Y Breadon; Paul Blair Odland; Daniel Bennett; Jack Longley; Gary S Wood
Journal:  JAMA Dermatol       Date:  2014-02       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.